UK Government to Boost R&D Spending
UK Government to Boost R&D Spending
The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.
UK Government to Boost R&D Spending
UK Government to Boost R&D Spending

The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.

The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.

business
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
Artificial Intelligence Shakes Up Drug Discovery
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Former Taiwanese National Academy Head Cleared of Corruption
Former Taiwanese National Academy Head Cleared of Corruption
Ashley Yeager | Jan 3, 2019
Wong Chi-huey, who was the president of Academia Sinica until 2016, was found not guilty of taking bribes from a pharmaceutical company.
“Co-op” Lets Users Barter DNA and Health Information for Shares
“Co-op” Lets Users Barter DNA and Health Information for Shares
Shawna Williams | Dec 7, 2018
LunaDNA receives Securities and Exchange Commission approval to treat the data as currency.
First Blockchain-based Genomic Data Marketplace Launches
First Blockchain-based Genomic Data Marketplace Launches
Shawna Williams | Nov 5, 2018
EncrypGen will enable individuals to sell their deidentified data for research.
Call to Stop Using the Term “Mesenchymal Stem Cell”
Call to Stop Using the Term “Mesenchymal Stem Cell”
Abby Olena | Sep 26, 2018
Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.
Opinion: A Modest Proposal to Address NIH Insanity
Opinion: A Modest Proposal to Address NIH Insanity
Henry J. Rozycki | Aug 22, 2018
Silicon Valley’s early-stage funding model could address a dearth of opportunities for young investigators just launching new projects.
Researchers React to Microsoft’s Acquisition of GitHub
Researchers React to Microsoft’s Acquisition of GitHub
Anna Azvolinsky | Jun 7, 2018
Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
SEC Charges Theranos With Fraud
SEC Charges Theranos With Fraud
Jim Daley | Mar 14, 2018
The company raised more than $700 million based on false claims to investors, according to the complaint.
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Jim Daley | Jan 31, 2018
Biotech stocks fell in response to the news. 
Should Healthy People Have Their Exomes Sequenced?
Should Healthy People Have Their Exomes Sequenced?
Ruth Williams | Mar 24, 2017
With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  
Johnson & Johnson to Acquire Swiss Biotech Firm for $30 Billion
Johnson & Johnson to Acquire Swiss Biotech Firm for $30 Billion
Joshua A. Krisch | Jan 26, 2017
With its purchase of Actelion, Johnson & Johnson’s acquires experimental treatments for pulmonary arterial hypertension and several rare diseases.
That Other CRISPR Patent Dispute
That Other CRISPR Patent Dispute
Kerry Grens | Aug 31, 2016
The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.
Former Affymetrix Employees Fail to Stop Thermo Fisher Takeover
Former Affymetrix Employees Fail to Stop Thermo Fisher Takeover
Bob Grant | Mar 22, 2016
Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.
Thermo Fisher to Acquire Affymetrix
Thermo Fisher to Acquire Affymetrix
Tracy Vence | Jan 11, 2016
The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.